Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > VRX Target now $29.00 US @ Conference next ...
View:
Post by aebestacey on Feb 13, 2017 11:26pm

VRX Target now $29.00 US @ Conference next ...

Valeant Pharma. (VRX-T, VRX-N). RBC maintains Outperform and price target of $29 (U.S.). The current price is $14.92. 

PR Newswire

LAVAL, Quebec, Feb. 13, 2017

LAVAL, Quebec, Feb. 13, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences:

  • 2017 RBC Capital Markets' Healthcare Conference on Thursday, February 23, 2017 at 9:00 a.m. ET at the New York Palace Hotel; and,
     
  • Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 8:30 a.m. ET at the Loews Miami Beach Hotel.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: https://ir.valeant.com/events-and-presentation.

Comment by yrmac on Feb 14, 2017 11:10am
Valeant (VRX, 14,97$ US): baisse de cible RBC Marchs des capitaux renouvelle une recommandation "performance de secteur" et abaisse sa cible. La socit pharmaceutique doit rapporter ses rsultats du quatrime trimestre le 28 fvrier. Douglas Miehm estime que le march focalisera surtout ce jour-l sur l'aperu de bnfice de la direction pour 2017, et de combien infrieur il sera celui de ...more  
VALEANT PHARMACEUTICALS INTL INC